Strategic Development, Safety & Regulatory Compliance, and Commercialization of Parenteral Delivery Systems
Projected to hit $8 billion by the end of 2024 in the US alone, the market for pre-filled syringes and auto-injectors continues to expand at an impressive rate. Numerous advantages such as ease of administration, enhanced safety, reduced risk of contamination, and accuracy of dosing, have made PFS & auto-injectors attractive over other delivery systems. Growth in the biologics market, rising preference for self-administrations which use pre-filled syringes, pen injectors, and autoinjectors, are propelling the growth of the market. This is why you cannot afford to miss Pharma Ed Resources’ Pre-filled Syringes & Auto-injectors Virtual Forum 2020. This two-day summit brings together thought-leaders and key decision makers to illuminate current and future trends in this key market.
There are no reviews yet.